Cargando…

Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies

Estradiol (E2) is a major hormone controlling women fertility, in particular folliculogenesis. This steroid, which is locally produced by granulosa cells (GC) within ovarian follicles, controls the development and selection of dominant preovulatory follicles. E2 effects rely on a complex set of nucl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauvin, Stéphanie, Cohen-Tannoudji, Joëlle, Guigon, Céline J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745567/
https://www.ncbi.nlm.nih.gov/pubmed/35008938
http://dx.doi.org/10.3390/ijms23010512
_version_ 1784630376480636928
author Chauvin, Stéphanie
Cohen-Tannoudji, Joëlle
Guigon, Céline J.
author_facet Chauvin, Stéphanie
Cohen-Tannoudji, Joëlle
Guigon, Céline J.
author_sort Chauvin, Stéphanie
collection PubMed
description Estradiol (E2) is a major hormone controlling women fertility, in particular folliculogenesis. This steroid, which is locally produced by granulosa cells (GC) within ovarian follicles, controls the development and selection of dominant preovulatory follicles. E2 effects rely on a complex set of nuclear and extra-nuclear signal transduction pathways principally triggered by its nuclear receptors, ERα and ERβ. These transcription factors are differentially expressed within follicles, with ERβ being the predominant ER in GC. Several ERβ splice isoforms have been identified and display specific structural features, which greatly complicates the nature of ERβ-mediated E2 signaling. This review aims at providing a concise overview of the main actions of E2 during follicular growth, maturation, and selection in human. It also describes the current understanding of the various roles of ERβ splice isoforms, especially their influence on cell fate. We finally discuss how E2 signaling deregulation could participate in two ovarian pathogeneses characterized by either a follicular arrest, as in polycystic ovary syndrome, or an excess of GC survival and proliferation, leading to granulosa cell tumors. This review emphasizes the need for further research to better understand the molecular basis of E2 signaling throughout folliculogenesis and to improve the efficiency of ovarian-related disease therapies.
format Online
Article
Text
id pubmed-8745567
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87455672022-01-11 Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies Chauvin, Stéphanie Cohen-Tannoudji, Joëlle Guigon, Céline J. Int J Mol Sci Review Estradiol (E2) is a major hormone controlling women fertility, in particular folliculogenesis. This steroid, which is locally produced by granulosa cells (GC) within ovarian follicles, controls the development and selection of dominant preovulatory follicles. E2 effects rely on a complex set of nuclear and extra-nuclear signal transduction pathways principally triggered by its nuclear receptors, ERα and ERβ. These transcription factors are differentially expressed within follicles, with ERβ being the predominant ER in GC. Several ERβ splice isoforms have been identified and display specific structural features, which greatly complicates the nature of ERβ-mediated E2 signaling. This review aims at providing a concise overview of the main actions of E2 during follicular growth, maturation, and selection in human. It also describes the current understanding of the various roles of ERβ splice isoforms, especially their influence on cell fate. We finally discuss how E2 signaling deregulation could participate in two ovarian pathogeneses characterized by either a follicular arrest, as in polycystic ovary syndrome, or an excess of GC survival and proliferation, leading to granulosa cell tumors. This review emphasizes the need for further research to better understand the molecular basis of E2 signaling throughout folliculogenesis and to improve the efficiency of ovarian-related disease therapies. MDPI 2022-01-03 /pmc/articles/PMC8745567/ /pubmed/35008938 http://dx.doi.org/10.3390/ijms23010512 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Chauvin, Stéphanie
Cohen-Tannoudji, Joëlle
Guigon, Céline J.
Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies
title Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies
title_full Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies
title_fullStr Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies
title_full_unstemmed Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies
title_short Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies
title_sort estradiol signaling at the heart of folliculogenesis: its potential deregulation in human ovarian pathologies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745567/
https://www.ncbi.nlm.nih.gov/pubmed/35008938
http://dx.doi.org/10.3390/ijms23010512
work_keys_str_mv AT chauvinstephanie estradiolsignalingattheheartoffolliculogenesisitspotentialderegulationinhumanovarianpathologies
AT cohentannoudjijoelle estradiolsignalingattheheartoffolliculogenesisitspotentialderegulationinhumanovarianpathologies
AT guigoncelinej estradiolsignalingattheheartoffolliculogenesisitspotentialderegulationinhumanovarianpathologies